| Posttransplant management: key points |
| • Albeit the limited experience, there seems to be a role for ruxolitinib in the peri- and posttransplant period. |
| • Optimal histological and molecular monitoring of MF after HSCT is still to be defined. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.